‘SAT-2 serotype’ disease vaccine started to apply to animals in Edi̇rne, Turkiye

Published Mar 18, 2023

Tridge summary

The Ministry of Agriculture and Forestry in Turkey has initiated vaccination studies against the SAT-2 serotype foot-and-mouth disease, following its outbreak in Iraq and later in some regions of Turkey. The ministry has developed a vaccine and is administering it to approximately 155 thousand cattle across the province of Edirne, with the aim of preventing disease transmission. The vaccine was developed in a week and sent to provincial directorates across the country. Breeders in Edirne have expressed relief at the quick development and distribution of the vaccine, but have also raised concerns about its availability and the impact of the disease and the restrictions it has imposed on animal mobility and markets.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

In order to combat SAT-2 serotype foot-and-mouth disease, which is also seen in some regions of Turkey after its emergence in IRAQ, vaccination studies were initiated by the Ministry of Agriculture and Forestry in Edirne, as well as throughout the country. The vaccine developed in the laboratories of the Ministry is administered by the veterinarian of the Provincial Directorate of Agriculture and Forestry to approximately 155 thousand cattle throughout the province, aiming to prevent disease transmission. The Ministry of Agriculture and Forestry took action after the SAT-2 serotype foot-and-mouth disease, which emerged in Iraq about 15 days ago, was seen in cattle in some regions of Turkey. The Ministry stopped animal mobility throughout the country, closed animal markets and places where live animals are sold, and started a work to combat the disease. The vaccine was developed in the Ministry's laboratories in a short period of about 1 week and sent to the Provincial Directorates ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.